C

Castle Biosciences

D
CSTL
USD
-0.972
(-2.8773%)
Market Closed
8,322.00
Volume
-0.48
EPS
-
Div Yield
-273.416660
P/E
910,043,095.60
Market Cap
Today
-2.8773%
1 Week
5.634%
1 Month
4.858%
6 Months
35.411%
12 Months
91.089%
Year To Date
52.039%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TUP
(%)
USD
N
NWL
-0.15
(-1.6069%)
USD
PG
PG
-0.22
(-0.1325%)
USD
HSY
HSY
2.99
(1.6748%)
USD
KMB
KMB
-1.18
(-0.8852%)
USD
C
CLX
-0.31
(-0.1878%)
USD
CL
CL
-0.515
(-0.5598%)
USD
KHC
KHC
-0.53
(-1.6298%)
USD
M
MKC
-0.43
(-0.5583%)
USD
C
CPB
-0.54
(-1.2067%)
USD

Title:
Castle Biosciences

Sector:
Healthcare
Industry:
Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Do you need help or have a question?
Contact Us